Marker profile of mesothelial cells versus ovarian carcinoma cells
- 15 June 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (6), 1065-1071
- https://doi.org/10.1002/ijc.2910430619
Abstract
We investigated the marker profile of human ascitic and cultured mesothelial cells, and compared it to that of ovarian carcinoma cells which are related in terms of their histogenesis, unrelated colon carcinomas being used as reference. Mesothelial and ovarian carcinoma cells could not be distinguished by (intermediate) filament typing, using monoclonal antibodies (MAbs) to keratins, vimentins and desmins. Colon carcinomas differed from mesothelial cells and ovarian carcinomas by the absence of keratin‐7 filaments. The epithelial marker BW 495/36 was completely negative on mesothelial cells and positive on all ovarian and colon carcinoma cells. While CEA was found on about 85% of all colon carcinomas, CEA expression on mesothelial cells and ovarian carcinoma cells was below 20%. The ovarian carcinoma markers (OV‐TL 3, OV‐TL 10, OC 125, MOV 18) were strongly positive on ovarian carcinomas and negative on colon carcinomas (or limited to traces of immunofluorescence on some samples). Although the mesothelial cells showed weak or negative reactivity with these markers, OC 125 antigen was found by immunoelectron microscopy on the surface of cultured mesothelial cells, and was shed in the culture supernatant at concentrations of 50, 28, and 25 CA 125 U/ml/104 positive cells. This suggests that mesothelial cells may be responsible for the synthesis of CA 125 in ascitic fluid. The data indicate that ovarian carcinomas, mesothelial cells and colon carcinomas can be distinguished using a combination of anti‐keratin antibodies with BW 495/36 and anti‐ovarian carcinoma markers.Keywords
This publication has 20 references indexed in Scilit:
- Elevation of CA 125 in patients with benign and malignant ascitesCancer, 1987
- The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesEuropean Journal of Cancer and Clinical Oncology, 1985
- Immunohistochemical localization and molecular characteristics of three monoclonal antibody‐defined epitopes detectable on carcinoembryonic antigen (CEA)International Journal of Cancer, 1985
- Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.Journal of Clinical Pathology, 1984
- Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleenJournal of Immunological Methods, 1983
- Keratin and Carcinoembryonic Antigen in Exfoliated Mesothelial and Malignant Cells: An Immunoperoxidase StudyAmerican Journal of Clinical Pathology, 1983
- Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in cultureCell, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebratesExperimental Cell Research, 1979